ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation [0.03%]
埃及心脏病专家共识关于血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在心血管结局的一级和二级预防中的应用：与CVREP基金会合作的2024年推荐意见
Mohamed Sobhy,Adel Eletriby,Hany Ragy et al.
Mohamed Sobhy et al.
Introduction: The renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in regulating blood pressure (BP), with dysregulation of RAAS resulting in hypertension and potentially heart failure (HF), myocardial inf...
Letter to the Editor Regarding 'Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)' [0.03%]
关于《Tafamidis 61 mg的患者特征与依从性吗？基于德国法定健康保险数据（IQVIA™ LRx）的回顾性分析》来信
Arnt V Kristen,Carsten Tschöpe,Stephanie Schwarting et al.
Arnt V Kristen et al.
A Response to: Letter to the Editor Regarding "Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)" [0.03%]
有关“Letter to the Editor Regarding 'Tafamidis 61 mgPatient Characteristics andPersistency？ARetrospectiveAnalysisofGermanStatutoryHealthInsuranceData（IQVIA™LRx）'"的回复
Sepideh Attal
Sepideh Attal
Real-World Application of Evolocumab Among Patients with Hyperlipidemia in Korea: A Multicenter Prospective Study [0.03%]
韩国高脂血症患者中Evolocumab的现实世界应用：一项多中心前瞻性研究
Min Chul Kim,Seung Hun Lee,Joon Ho Ahn et al.
Min Chul Kim et al.
Introduction: Elevated low-density lipoprotein cholesterol (LDL-C) is a major residual risk factor among patients with acute coronary syndrome (ACS). In the absence of sufficient real-world evidence, this observational (n...
National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000-2021 [0.03%]
美国2000-2021年居民阿司匹林使用与支出的国家趋势：医疗支出面板调查分析
Harshith Thyagaturu,Shafaqat Ali,Karthik Seetharam et al.
Harshith Thyagaturu et al.
Introduction: Since its invention in 1897, aspirin (ASA) has been the most widely used and cost-effective antiplatelet agent to prevent and treat atherosclerotic cardiovascular disease (ASCVD). We aimed to study the trend...
Shyon Parsa,Sneha S Jain,Olu Akinrimisi et al.
Shyon Parsa et al.
Direct oral anticoagulants have a dose-dependent increased bleeding risk which limits use in certain populations. Studies in both animals and humans with inherited variations in factor XI levels provide a theoretical basis for a drug target...
All-Cause Mortality of Atrial Fibrillation and Heart Failure in the Same Patient: Does the Order Matter? [0.03%]
同一位患者中的心房颤动和心脏衰竭全因死亡率：顺序有影响吗？
Tímea Papp,György Rokszin,Zoltán Kiss et al.
Tímea Papp et al.
Introduction: Atrial fibrillation (AF) and heart failure (HF) often coexist due to the common elements of the pathomechanism they share. The potential significance of the order these entities present in the same patient i...
Richard G Trohman
Richard G Trohman
Although significant strides have been made in non-pharmacologic management of atrial fibrillation (AF), these treatments remain a work in progress. While catheter ablation is often effective for management of paroxysmal AF, it is less succ...
Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study [0.03%]
低INR（＜2）特殊人群使用四因子凝血酶原复合物注射液的安全性和有效性：一项上市后监测研究
Masahiro Yasaka,Fumihiko Shimizu,Yuki Niwa et al.
Masahiro Yasaka et al.
Introduction: We previously conducted a prospective, observational post-marketing surveillance study to assess the safety and effectiveness of four-factor prothrombin complex concentrate (4F-PCC) for rapid vitamin K antag...
Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review [0.03%]
动脉粥样硬化炎症靶向治疗新进展：叙事综述
Rafael Zubirán,Edward B Neufeld,Amaury Dasseux et al.
Rafael Zubirán et al.
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality despite effective low-density lipoprotein cholesterol-targeted therapies. This review explores the crucial role of inflammation in the residua...